Citation tools
"Impact on costs and quality-adjusted-life-years of treat-to-target treatment strategies initiating methotrexate, or tocilizumab, or their combination in early rheumatoid arthritis. 5 year economic evaluation.." The Journal of Rheumatology
(2020):
jrheum.200067.
Web. 17 April. 2024.